Impact Biomedical (IBO) Profit After Tax (2022 - 2026)
Impact Biomedical (IBO) posted Profit After Tax of -$2.3 million for Q1 2026, down 55.58% on a QoQ basis from -$1.5 million in Q3 2025, and down 78.95% year-over-year from -$10.9 million in Q1 2025.
Impact Biomedical (IBO) Profit After Tax (2022 - 2026) Analysis & Trends
Impact Biomedical's Profit After Tax history runs 5 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- Quarterly Profit After Tax fell 78.95% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.4 million (up 22.55% YoY) and the FY2024 annual result came in at -$24.7 million, down 460.65% from the prior year.
- Profit After Tax was -$2.3 million for Q1 2026 at Impact Biomedical, down from -$1.5 million in the prior quarter.
- Across five years, Profit After Tax topped out at $4.2 million in Q3 2024 and bottomed at -$27.1 million in Q4 2024.
- A 5-year average of -$3.7 million and a median of -$1.3 million in 2023 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 460.83% in 2024, while the deepest fall reached 2049.72% in 2024.
- Impact Biomedical's Profit After Tax stood at -$3.4 million in 2022, then soared by 62.54% to -$1.3 million in 2023, then slumped by 2049.72% to -$27.1 million in 2024, then surged by 94.58% to -$1.5 million in 2025, then slumped by 55.58% to -$2.3 million in 2026.
- Business Quant data shows IBO's Profit After Tax at -$2.3 million in Q1 2026, -$1.5 million in Q3 2025, and -$14.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -14.35 Mn |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | -27.11 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | -884,000.00 |
| Mar 31, 2024 | -998,000.00 |
| Dec 31, 2023 | -1.26 Mn |
| Sep 30, 2023 | -1.18 Mn |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -849,000.00 |
| Dec 31, 2022 | -3.37 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -799,000.00 |